ID: ALA3394245

Max Phase: Preclinical

Molecular Formula: C14H9F3N2O3S

Molecular Weight: 342.30

Molecule Type: Small molecule

Representations

Canonical SMILES:  C[S+]([O-])c1cc(-c2cccc(OC(F)(F)F)c2)[nH]c(=O)c1C#N

Standard InChI:  InChI=1S/C14H9F3N2O3S/c1-23(21)12-6-11(19-13(20)10(12)7-18)8-3-2-4-9(5-8)22-14(15,16)17/h2-6H,1H3,(H,19,20)

Standard InChI Key:  LDLFTWUQLJNHAW-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 342.30

Molecular Weight (Monoisotopic): 342.0286

AlogP: 2.55

#Rotatable Bonds: 3

Polar Surface Area: 88.94

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 6.67

CX Basic pKa:

CX LogP: 1.20

CX LogD: 0.60

Aromatic Rings: 2

Heavy Atoms: 23

QED Weighted: 0.87

Np Likeness Score: -1.08

References

1. Naik M, Raichurkar A, Bandodkar BS, Varun BV, Bhat S, Kalkhambkar R, Murugan K, Menon R, Bhat J, Paul B, Iyer H, Hussein S, Tucker JA, Vogtherr M, Embrey KJ, McMiken H, Prasad S, Gill A, Ugarkar BG, Venkatraman J, Read J, Panda M..  (2015)  Structure guided lead generation for M. tuberculosis thymidylate kinase (Mtb TMK): discovery of 3-cyanopyridone and 1,6-naphthyridin-2-one as potent inhibitors.,  58  (2): [PMID:25486447] [10.1021/jm5012947]

Source

Source(1):

• Scientific Literature